make or break, page-3

hahaha I had the same thoughts. If successful OK, but otherwise...throw in the towel?!

I guess all the money is on the oil and gas. This has been under trial for years, but is about the only product still on the cooker. I had hopes for the air-conditioning and dental products, but long time and no news (usually means it's dead in this company). The Japanese aircon trials falling over because of a lack of Legionnaire bacteria this year seemed far-fetched..

The language lately has become more cautious. Even saying that at least we'd get a lot of data even if the trials don't succeed. The tone is gloomy, but maybe that's just being realistic or prudent. No-one wants to relive the shock of going from CIBA having successful trials to the product suddenly being completely unworkable and please don't come back.

The oil and gas has been under trials for a loooong time, and not much news has come from it. It's not just Commercial Microbiology that's had this product under trial. Even in it's darkest days BOS couldn't dig up good news from the trials.

I don't think the oil and gas product is fully optimised yet. BOS would like to do more to increase effectiveness and reduce costs. So I'm not expecting a bombshell result from Conoco. But I’m desperately hopeful conoco will at least see possibility in the product and put a few dollars in the kitty.

I guess the AGM is your best bet to getting some insight. I've found the board to be very informative in the past. I note that the meeting is now at the worksite. saving pennies - good on them. Last year only about 8 investors showed up - so no use spending up big on the AGM venue.

Anyway, I have my fingers crossed, but I am getting rather worried about BOS.